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Background: The establishment of high producer is an important issue in Chinese hamster ovary (CHO) cell culture
considering increased heterogeneity by the random integration of a transfected foreign gene and the altered
position of the integrated gene. Fluorescence-activated cell sorting (FACS)-based cell line development is an
efficient strategy for the selection of CHO cells in high therapeutic protein production.
Results: An internal ribosome entry site (IRES) was introduced for using two green fluorescence protein (GFP)
fragments as a reporter to both antibody chains, the heavy chain and the light chain. The cells co-transfected with
two GFP fragments showed the emission of green fluorescence by the reconstitution of split GFP. The FACS-sorted
pool with GFP expression had a higher specific antibody productivity (qAb) than that of the unsorted pool. The qAb
was highly correlated with the fluorescence intensity with a high correlation coefficient, evidenced from the
analysis of median GFP and qAb in individual selected clones.
Conclusions: This study proved that the fragment complementation for split GFP could be an efficient indication
for antibody production on the basis of high correlation of qAb with reconstitution of GFP. Taken together, we
developed an efficient FACS-based screening method for high antibody-producing CHO cells with the benefits of
the split GFP system.
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Chinese hamster ovary (CHO) cells are one of the most
widely used host cells for therapeutic protein produc-
tion. The selection of CHO cells for high therapeutic
protein production is of particular interest in CHO cell
culture for a wide variety of individual clones for prod-
uctivity from a random integration and gene amplifica-
tion system [1]. Due to the large number of candidates
that need their productivity evaluated, an efficient high-
throughput cell screening system needs to be developed.
Flow cytometry can efficiently evaluate a number of
cells at the single-cell level in a short time and isolate a
single clone from sub-populations. Various fluorescence-
activated cell sorting (FACS)-based cell screening meth-
ods have been developed for CHO cells with the benefits
of flow cytometry [1]. The use of an antibody conjugated* Correspondence: eglee@kribb.re.kr
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reproduction in any medium, provided the orwith a fluorescent molecule, which is the target to the
membrane-retained therapeutic proteins has been used
to find high-producing clones in the combination with
FACS. Although its mechanism has not been fully eluci-
dated, the incubation of antibody-producing CHO cells
at 4°C could lead to the transient association of the desired
antibody with the cell surface [2]. The target antibody at
cell surface can be detected by another fluorescent-
conjugated antibody and the highly fluorescent-labeled
clones are isolated as high producers using FACS system,
evidenced from correlating the mean fluorescence inten-
sity with specific productivity (q). Similarly, to capture the
secreted protein in a small droplet or matrix generated on
the cell surface, gel microdrop technology and affinity cap-
ture surface display method combined with fluorescent-
conjugated antibody have been developed [3,4]. Instead of
direct measurement of desired antibody by anchoring
membrane, the cell surface reporter, CD20 not normally
expressed in CHO cells, is co-expressed with the target. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the high producer is detected using a fluorescent-conjugated
anti-CD20 antibody [5].
Being different from the direct detection of a target
protein, intracellular fluorescent materials, such as green
fluorescence protein (GFP) and yellow fluorescence pro-
tein (YFP), were a widely used fluorescent protein for
FACS because of easy activation without co-factors and
substrates. Meng et al. (2000) evaluated the usefulness of
GFP as an indicator for finding high-producing clone
when it is co-expressed with therapeutic protein in one
vector system [6]. Due to the close relationship between
fluorescence intensity and q, clones with high q could
easily be isolated from sub-populations based on fluores-
cence level using FACS. In a similar way, clones with
high fluorescence level were selected as for high q in
FITC-conjugated MTX-mediated gene amplification sys-
tem on the basis of correlation of q with amplified gene
copy number [7]. However, in the case of isolation of
antibody-producing cells, there is a limitation in the
applications of these systems because antibody is com-
posed of two fragment proteins which are heavy and
light chains. Therefore, Sleiman et al. (2008) developed
two color fluorescent protein-based FACS to select clone
possessing the high level of the heavy chain and the light
chain by detecting GFP and YFP, respectively [8].
For the characteristics of an antibody composed of
two fragments, a heavy chain and a light chain, the frag-
ment complementation system can be useful in finding
antibody-producing cells. Previously, Bianchi and McGrew
(2003) developed an efficient system for the selection of
CHO cells with high levels of both antibody chains using a
DHFR fragment [9]. The fragment complementation sys-
tems for split GFP by means of anti-parallel leucine zipper
and EF-hand calcium binding motifs of calbindin D9k
have been reported [10-12]. Expression of two fragments
of GFP does not achieve folding and fluorescence of GFP
by itself. However, GFP is reassembled through the intro-
duction of strong mediator such as anti-parallel leucine
zipper and EF-hand calcium binding motifs of calbindin
D9k by non-covalent reconnection. Despite the merits in
using split GFP, such as the extensive use of flow cytome-
try and efficient complementation system for GFP, there
is, to date, no report introducing it related to cell line de-
velopment in mammalian cell culture. In the present
study, we developed a new cell screening method for high
antibody-producing CHO cells based on the reassembly of
split GFP combined with FACS.
Results and discussion
To evaluate the role of split GFP as a reporter for antibody
production, we constructed an overexpression vector for
split GFP and antibody chains expressed simultaneously.
Figure 1A shows the schematic diagram representing theway the assembly of split GFP works as a reporter for the
selection of antibody-producing cells. The GFP fragments,
called N-GFP and C-GFP (described in the ‘Methods’ sec-
tion), are co-linked with a light chain and heavy chain gene
using an IRES sequence, respectively. These constructs con-
taining an IRES sequence, pNGFP-Light and pCGFP-
Heavy, led us to hypothesis that the transcription level of
the light and heavy chains is highly correlated with that of
N-GFP and C-GFP. From this hypothesis, our speculation
extends to the idea that the high GFP-expressing clone may
be the high antibody-producing clone.
To confirm both the antibody expression and the as-
sembly of the GFP with a constructed vector, a bicistro-
nic vector containing GFP fragments and an antibody
gene, pNGFP-Light and pCGFP-Heavy, was transfected
into HEK293T cells. As a control, a GFP-overexpressing
vector, pEGFP-C1, was also transfected into HEK293T
cells. Figure 1B shows the confocal microscopic images
of transfected cells and antibody titer produced from
them. The emission of green fluorescence from reconsti-
tuted split GFP was efficiently detected when the two
fragments were co-expressed. In addition, the cells with
green fluorescence could produce the antibody simultan-
eously. The same results were confirmed in CHO-K1
cells (data not shown). Accordingly, we proceeded with
these constructs to evaluate the efficiency of this screen-
ing system in CHO cells.
To investigate whether the sorted cells by FACS are
the antibody-producing CHO cells, the CHO cells with
intracellular green fluorescence (First sort pool and Sec-
ond sort pool) were generated by two rounds of FACS
from the CHO cells co-transfected with pNGFP-Light
and pCGFP-Heavy (Unsorted pool). Figure 2 shows the
flow cytometry analysis and specific antibody productiv-
ity (qAb) of unsorted and FACS-sorted cells. The dis-
crimination of cells with green fluorescence was performed
on a FITC/SSC diagram. The percentage of the cell popula-
tion with GFP expression in the First sort pool and Second
sort pool was much higher than that in the Unsorted pool.
Interestingly, the increase in qAb was highly associated with
the increase in the cell population with GFP expression.
Taken together, we found that the FACS-sorted cells with
GFP expression are the antibody-producing CHO cells.
To evaluate the efficiency of split GFP-based clone se-
lection for high antibody-producing cells, individual
clones were isolated from the Unsorted pool and the
Second sort pool by the limiting dilution method. Table 1
shows the distribution of 116 isolated clones from the
Unsorted pool and the Second sort pool with regard to
antibody titer, respectively. All of the Unsorted pool-
derived clones have low antibody production (less than
1 mg/L). Eighty-two out of 116 clones in the Second
sorted pool have antibody production exceeding 1 mg/L.
Moreover, there are four clones having over 10 mg/L in
ApEGFP-C1
Ab = 0.3 0.2 µg/L Ab = 0.2 0.1 µg/L
Ab = 0.1 0.0 µg/L Ab = 35.0 3.6 µg/L
pNGFP-Light
pCGFP-Heavy pNGFP + pCGFP
B
Figure 1 New cell line development for high antibody-
producing mammalian cells. (A) Schematic diagram for the split
GFP-based cell screening method. (B) Confocal microscopic images
of cells transfected with a GFP-overexpressing vector (pEGFP-C1) or
bicistronic vector having GFP fragements and both antibody chains
(pNGFP-Light and pCGFP-Heavy). After transfection with these
vectors, the cells were cultivated for two days at 30°C. DAPI was
used for nucleus staining. Antibody titer was quantified from culture
supernatant by ELISA.
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none in the Unsorted pool-derived clones. Altogether,
the clone selection with split GFP-based FACS appears
to be an efficient strategy to select high antibody-
producing CHO cells.
A major issue in the development of a cell screening
method using a reporter is to verify the co-relationship
between the expression level of the reporter and the
antibody. Especially, the screening system dealing with
intracellular reporter should be evaluated because anti-
body is generally secreted protein. In the same context,
previous reports utilizing a fluorescent protein as an
intracellular reporter proved the mutual relation be-
tween productivity of desired protein and fluorescence
intensity [6,8].
To address this issue, the median GFP and qAb of 30
selected clones were estimated. Figure 3 shows the rela-
tionship of the median GFP and qAb for individual
selected clones. The qAb is highly correlated with the
fluorescence intensity as indicated by the high correl-
ation coefficient (R2 = 0.8947). Accordingly, we con-
firmed that the selected clone having high fluorescence
intensity by GFP-based cell sorting is the high antibody
producer with high qAb.
Another issue that arises with the usage of intracellular
reporter is the determination of the optimum time-point
for sorting and metabolic burden by co-expressing re-
porter gene. Unlike the use of non-split fluorescent pro-
tein, we can exclude the issue of determining the
optimal point in split fluorescent protein because the
split fluorescent protein can be assembled at specific
conditions, such as low temperature in the case of split
GFP. Previously, Bochkov and Palmenberg (2006)
showed that the level of gene expression linked with
attenuated IRES was about 11-fold lower than wild-type
IRES [13]. Also, the modified form of GFP with
increased fluorescence intensity was reported [14]. The
introduction of attenuated IRES and improved form of
GFP can be a solution to reduce the metabolic burden
of fluorescent protein.
The intracellular fluorescent protein-based FACS for
clone selection in rCHO cells is a reasonable strategy as it
does not require complex preparation steps to capture
and detect a secreted antibody. Previously, Sleiman et al.
(2008) developed an efficient dual intracellular auto-
fluorescent protein-associated FACS to select antibody-
producing CHO cells with a high level of both antibody
chains [8]. In this system, two reporters, GFP and YFP, are
applied for the heavy and light chain, respectively. In gen-
eral, a correct compensation is necessary for accurate ana-
lysis when more than two colors are used as a parameter
in flow cytometry [15]. Moreover, a similar level of fluor-
escence intensity in GFP and YFP does not guarantee a
similar expression level of the heavy chain and the light
Unsorted pool
0.5%
First sort pool Second sort pool
%3.86%5.6
qAb = 0.02 pg/cell/day qAb = 0.23 pg/cell/day qAb = 2.71 pg/cell/day
Figure 2 Flow cytometry analysis for green fluorescence and qAb of unsorted cells and FACS-sorted cells having reconstituted GFP. Dot
plots of SSC versus log-FITC fluorescence are shown. Each dot represents a single cell; 10,000 cells are represented in each plot. The line in the
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an absolute value. Also, the split GFP-based cell screening
method developed in this study is advantageous in that
one reporter is introduced for quantitative analysis. By
employing this type of complementation system, we can
omit the process of compensation.
The additional validation for dynamic range of the
GFP assay and long-term stability of constructed cell
line may be needed to successfully apply the split GFP-
based cell screening method for commercial production
cell line. The expanded result for dynamic range of
GFP expression in high antibody-producing clones with
enhanced qAb via gene amplification system and/or cis-
acting element for augmenting gene expression may be
helpful to meet the industrial standard. The genetic in-
stability of antibody-producing CHO cell line during
long-term culture in the absence of selective pressure is
one of main issues in CHO cell culture [16]. The data
provided from long-term culture with constructed cell
lines based on split GFP system to determine the associ-
ation of GFP expression with reduced qAb will be an
interesting extension of this work.Table 1 Distribution of isolated clones from the Unsorted
pool and the Second sort pool for antibody titer
Criterion (mg/L)a Unsorted pool Second sort pool
< 0.5 115/116 33/116
0.5 – 1 1/116 1/116
1 – 5 0/116 28/116
5 – 10 0/116 50/116
> 10 0/116 4/116
aCells were inoculated at a concentration of 3 × 105 cells/mL into a 6-well
plate. The samples were measured by ELSIA after 3-days cultivation.Conclusions
The considerable clonal variation attributed from transfec-
tion and gene amplification makes it difficult to establish
high-producing rCHO cell line. For large number of
analytes, it is necessary to develop an efficient high-
throughput cell screening system. In this study, we
developed an efficient screening method based on recon-
stitution of split GFP to select high antibody-producing
CHO cells using a FACS analysis. On the basis of correl-
ation between q and fluorescence intensity by reconstitut-
ing GFP, the fragment complementation system for split
GFP could be a powerful tool for antibody production in
CHO cells.qAb (pg/cell/day)










Figure 3 Relationship between the qAb and green fluorescence
intensity in 30 selected clones. Median green fluorescence
intensity (GFP mean) and qAb were measured by flow cytometry
analysis and ELISA, respectively. The qAb and GFP mean (X, Y) pairs
for each clone were plotted to calculate the correlation coefficient
(R2).
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Plasmid construction
A modified pIRES vector (BD Biosciences Clontech) with
wild-type IRES was used for the construction of pNGFP-
Light and pCGFP-Heavy. The light and heavy chain
genes were kindly provided by Dr. J. S. Yoo, Pharmabcine
Co., Ltd. They were inserted into MCS-A of the pIRES
vector to yield pIRES-Light and pIRES-Heavy, respect-
ively. The GFP coding sequence was obtained from
pIRES2-EGFP (BD Biosciences Clontech) by PCR ampli-
fication. DNA construct for Calbindin D9k including EF1
and EF2 were synthesized in Bioneer Co., Ltd. as
described previously [10]. N-GFP encoding N-terminal
GFP (amino acid residue 1–158) linked with EF1 via
GGSGSGSS and C-GFP encoding C-terminal GFP
(amino acid residue 159–239) linked with EF2 via
TSGGSG were made by a sequential PCR method as
described previously [12,17]. Then, they were inserted
into MCS-B of the pIRES vector resulting in pNGFP-
Light and pCGFP-Heavy, respectively.Cell line and culture maintenance
The CHO-K1 cells (ATCC CRL-61) were plated onto
25 cm2 T-flasks (Nunc), and attached for 24 h before
transfection. The CHO-K1 cells (1 × 106 cells) were co-
transfected with pNGFP-Light (4 μg) and/or pCGFP-
Heavy (4 μg) using LipofectamineTM 2000 (Invitrogen)
according to the manufacturer’s protocol. Drug selection
was carried out for three weeks by seeding 1 × 104 cells/
mL in 75 cm2 T-flasks (Nunc) containing Roswell Park
Memorial Institute (RPMI; Invitrogen) supplemented
with 10% fetal bovine serum (FBS; Invitrogen) and
500 μg/mL G418 (Invitrogen). After drug selection, a
stable pool, called the Unsorted pool, was maintained
for three days at a concentration of 1 × 105 cells/mL.
The Unsorted pool was cultivated for two days at 30°C
and then the top 1% of the fluorescence intensity in the
Unsorted pool using FACS analysis (See below) was col-
lected and called the First sort pool. The Second sort
pool was prepared from the top 1% of the fluorescence
intensity of the First sort pool using the same procedure.Batch culture
Exponentially growing cells were inoculated at a concen-
tration of 0.7 × 105 cells/mL into 25 cm2 T-flasks (Nunc)
containing 5 mL of RPMI supplemented with 10% FBS
and 500 μg/mL G418, and the plates were incubated in a
humidified 5% CO2/air mixture at 37°C. Periodically, the
25 cm2 T-flasks were sacrificed for determining the vi-
able cell concentration. The cell concentration and via-
bility were estimated with a Cytolecon automated cell
imaging counter (CYT-100; ECI Inc.) using the trypan
blue dye exclusion method. Culture supernatants, aftercentrifugation, were aliquoted and kept frozen at −70°C
for later analyses.
Enzyme-linked immunosorbent assay (ELISA)
The secreted antibody concentration was quantified by
an enzyme linked immunosorbent assay (ELISA). Briefly,
96-well plates (Nunc) were coated with anti-human IgG
(Sigma) and blocked with 2% bovine serum albumin
(BSA; Sigma) in phosphate buffered saline (PBS) con-
taining 0.1% Tween-20 (Sigma). Human IgG standard
(Sigma) and culture supernatants diluted with a blocking
buffer were loaded into each well and treated with per-
oxidase conjugated goat anti-human IgG (Sigma) in the
blocking buffer. 3,3',5,5'-tetramethyl benzidine (TMB;
Sigma) was used as a substrate and 1 M H2SO4 was used
to stop the reaction. Absorbance was measured by an
UV ELISA reader (Bio-Rad) at 450 nm.
Fluorescence-activated cell sorting (FACS) analysis
The cells were cultivated for two days at 30°C and then
were resuspended with PBS. The FACSAria™ system (BD
Biosciences Clontech) was used to estimate the green
fluorescence intensity of various clones as described pre-
viously [18]. Green fluorescence at 525 nm was detected
through an FL1 set at a PMT voltage of 400, with a loga-
rithmic gain. Ten thousand cells were analyzed for each
sample.
Fluorescence microscopy
The HEK293T cells (ATCC CRL-11268) were plated onto
RS-treated Lab-TekWII Chamber Slides (Nunc), and
attached for 24 h before transfection. For transient expres-
sion, HEK293T cells (1 × 105 cells) were co-transfected
with pNGFP-Light (0.4 μg) and/or pCGFP-Heavy (0.4 μg)
using LipofectamineTM 2000 (Invitrogen) according to the
manufacturer’s protocol [19]. Transfected cells were culti-
vated for two days at 30°C and then were fixed in 3.7% for-
maldehyde in PBS for 20 min. The chambers were
removed and the slides were sealed with cover slips after
adding a Vectashield mounting medium (Vector Labora-
tories) with DAPI for nucleus staining. All images were
collected by an LSM 510 confocal laser-scanning micro-
scope (Zeiss) and processed using the Adobe Photoshop
software.
Evaluation of specific antibody productivity (qAb)
The specific antibody productivity (qAb) was evaluated as
described previously [20]. The qAb was calculated from
the plot of antibody concentration versus the time inte-
gral of viable cells during day 2 and day 4.
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